Get started

Legends

Legend Biotech Reports First Quarter 2024 ResultsLegend Biotech Corporation ( NASDAQ:LEGN ), a global leader in cell therapy, reported its first quarter 2024 unaudited financial results and key corporate highlights. The company made significant progress in the first quarter, with label expansions for CARVYKTI in the U.S., Europe, and Brazil, which have changed the treatment paradigm for multiple myeloma and enabled more patients to receive the transformative therapy earlier in the course of their disease. With more patients needing access to CARVYKTI, Legend has increased its manufacturing capacity and scaled up operations to reach its goal of 10,000 annual doses by the end of 2025. Regulatory updates for CARVYKTI include approval by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD) and are refractory to lenalidomide. The European Commission (EC) granted approval for the label expansion of CARVYKTI® for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least one prior therapy, including an immunomodulatory agent and a proteasome inhibitor, have demonstrated disease progression on the last therapy, and are refractory to lenalidomide. Legend and Johnson & Johnson entered into a Master Manufacturing and Supply Services Agreement with Novartis Pharmaceuticals Corporation to supplement their existing manufacturing capabilities and increase commercial supply of CARVYKTI®. The company also published its inaugural Environmental, Social & Governance (ESG) report, which aligns with the Sustainable Accounting Standards Board (SASB) Biotechnology and Pharmaceutical sector standards, shares ESG data collection and disclosure roadmap, and future growth strategy for good corporate citizenship. In December 2017, Legend Biotech entered into an exclusive worldwide collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company, to develop and commercialize cilta-cel (the Janssen Agreement). First Quarter 2024 financial results showed that license revenue was $12.2 million, collaboration revenue was $78.5 million, and the cost of license and other revenue for the three months ended March 31, 2024 was $5.6 million. Research and development expenses were $101.0 million for the first quarter of 2024, compared to $84.9 million for the same period in 2023. Administrative expenses were $31.9 million for the first quarter of 2024, primarily due to the expansion of administrative functions and infrastructure to increase manufacturing capacity. Selling and distribution expenses were $24.2 million for the first quarter of 2024, compared to $18.0 million for the same period in 2023. Net loss for the first quarter of 2024 was $59.8 million, compared to a net loss of $112.1 million for the same period in 2023. Cash position as of March 31, 2024, was $1.3 billion.
NASDAQ:LEGN
by DEXWireNews
Buying Astralis part 2Again, following up on the previous analysis posted I am repeating the buy signal, and adding more to my position. Please, don't consider this a "loss chase" but merely part of my strategy to gradually build up a stock portfolio. Astralis' Origen team managed to win their matches this weekend, securing them a tied spot for the first place in the LEC Spring Around the time of the annual report, Astralis might even have won enough matches in the LEC to actually mention that they're (If they are at that point) qualified for some of the mid-year invitational leagues. Each league that Astralis' teams qualified for, or owns spots in, is money for us as shareholders. More exposure means better sponsor deals. These things, combined with the excellent opportunity for Astralis Group to showcase a remarkable 2019 result, and some great expectations for 2020, I think, will spark an impulse wave. This earnings report will also be Astralis Group's first time to speak to the shareholders, so I am expecting the price to pick up rapidly upon the release of their first report, since bringing in over 5000 new individual investors.
ALong
by UnknownUnicorn560420
Legends is going to 2x In MidTerm !!!BITTREX:LGDBTC is almost at bottom, Its all time high is 0.001+ btc, Now price is at 8k satoshi, Technically its resistance line is almost broken, So we can expect 2x easily in Upcoming Days.. Also its a Alts Season, all coins already started Pumping, this coin started too.. *****If You Like My Ideas,then hit the like button & Follow me for Latest Updates..****** ***This information is not a recommendation to buy or sell. It is to be used for educational purposes only.*** " Be Happy, Be Disciplined & Keep Smiling "
L
by iamiyaranjan
Legends (LGD) Confirmed Breakout (890%+ Profits Potential)I was given a tool today to check out "news" and events for all sorts of cryptocurrency coins/projects. After looking at Legends Room, I can see the team behind this project is organizing an event/meet up in Las Vegas tomorrow (13th Jan). So, is this going to make our trade stronger? Will this help move the price or build up momentum? If yes, then we'll take it. We can use this to our advantage, this might be something that can help improve our trade but in the meantime, let's look at the charts, I believe they have something to say. Our trade today is for Legends Room (LGD). I believe we can make some money trading this coin. I truly do... let's look at the charts. *** Legends (LGD) Trade Analysis & Instructions by Alan Masters *** >>> Instructions Buy-in: 0.00016 - 0.00022 Note: What this means is that you can buy this coin as long as the price is below 0.0002100 btc. Targets: (1) 0.000462 (2) 0.000662 (3) 0.000982 (4) 0.001492 Stop-loss: 0.000096 >>> Indicators - A strong breakout can be seen on the daily chart, which happened on the 25th December. You might look at the chart and think that the increase in price is small, the candles are not so big based on the last all time high, but when you look at the price swings closely after this breakout, we are talking about a 100%+ price increase. So this is a strong breakout, and we are now in this new trend. - If I draw a channel on the chart above, you can see clearly what I am talking about. This channel can be easily broken. - The weekly chart is pretty basic but really strong. All the indicators are strong. Retrace and consolidation are needed and are a normal part of the market cycles, so this will be part of this trade as well. - Low trading volume signals that the action is yet to start, this allows for plenty of room for growth. >>> My Message To You Today: More Money Today, let's focus on making even more money. Remember that all you need to do is buy and wait. While you are waiting you hold. Hold your coins. It is pretty simple. You buy and hold, and hold while you wait. The next step are the targets, that's it. You are in profit now. You can sell the targets in whatever way you want. You can sell a small amount on each target, you can sell everything, it is up to you. You are in profits. So buy and hold, then sell on target. That is actually how you get to the profits... with patience. Namaste. Mantra: "Om Stanesha Vahtu Nevehem"
LLong
by AlanSantana
138
LegendsRoom's Cup & Handle for the Main Event On Saturday I'll update this one in a minute showing the 24 hr chart but yeah. I just bought this coin mostly because on their twitter they were gonna host a Main event party for people so yeah... obviously it was bound to go up. When you check their twitter, they mentioned that they were almost filled up, so hopefully the traders will see the CUP AND HANDLE despite its rather... explicit nature of the coin. Would post their twitter, but I may get in trouble by the mod police. Follow me on twitter for calls and memes
LLong
by Ravness
6